DISEASE PROGRESSION AND MORTALITY IN NEOPLASTIC MYA-ARENARIA IN THE FIELD

Four 6-mo mark-and-recapture experiments conducted in Long Island Sound, USA, from 1988 to 1990, involving approximately 2250 individual observations, demonstrated that under natural conditions significantly higher mortality (p << 0.001, chi-square test) occurred among Mya arenaria (L.) with hematopoietic neoplasia than those diagnosed as non-neoplastic. Using a blood-screening technique, the clams were diagnosed and placed in one of three diagnostic groups based on the severity of the disease (the percentage neoplastic cells per total number of blood cells): non-neoplastic (NN), 0%; low-severity neoplastic (LSN), < 50%; high-severity neoplastic (HSN), > 50%. Mortality of those clams initially diagnosed as HSN ranged from 48% to 78%, depending on the test period, as compared to 3% to 21% for the non-neoplastic. Mortality in the LSN treatment varied from 8% to 34%. Both progression and remission were evident in clams at all stages of the disease. Mortality and rates of progression and remission in individuals appeared to be linked to water temperatures. Differential mortality may be responsible for the apparent seasonal cycle of prevalence in populations.